<HTML>
<HEAD>
<TITLE>PEDIATRIX MEDICAL GROUP, INC. FORM S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>As filed with the Securities and Exchange Commission on December&nbsp;9, 2004</B>



<P align="right" style="font-size: 10pt"><B>Registration
No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>



<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">





<P align="center" style="font-size: 14pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>Washington, DC 20549</B>
</DIV>

<P align="center" style="font-size: 18pt"><B>FORM S-8</B>


<P align="center" style="font-size: 10pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B>



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="20%" align="center">


<P align="center" style="font-size: 24pt"><B>PEDIATRIX MEDICAL GROUP, INC.</B>

<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="90%" align="center"></DIV>


<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="65%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Florida</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>65-0271219</B></TD>
</TR>

<TR style="font-size: 1px">
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of incorporation<BR>or
organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer<BR>
Identification Number)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>1301 Concord Terrace<BR>
Sunrise, Florida 33323-2825</B>


<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="40%" align="center"></DIV>


<DIV align="center" style="font-size: 10pt">(Address of Principal Executive Offices<B>)</B></DIV>



<P align="center" style="font-size: 10pt"><B>Pediatrix Medical Group, Inc. 2004 Incentive Compensation Plan<BR>
Pediatrix Medical Group of Puerto Rico Thrift and Profit Sharing Plan<BR>
Magella Healthcare Corporation Stock Option and Restricted Stock Purchase Plan</B>



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="90%" align="center">


<DIV align="center" style="font-size: 10pt">(Full title of the Plans)</DIV>



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="20%" align="center">



<P align="center" style="font-size: 10pt"><B>Thomas W. Hawkins, Esq.<BR>
Senior Vice President,<BR>
General Counsel and Secretary<BR>
Pediatrix Medical Group, Inc.<BR>
1301 Concord Terrace<BR>
Sunrise, Florida 33323-2825</B>


<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="30%" align="center"></DIV>


<DIV align="center" style="font-size: 10pt">(Name and address of agent for service)</DIV>



<P align="center" style="font-size: 10pt"><B>(954)&nbsp;384-0175</B>


<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="40%" align="center"></DIV>


<DIV align="center" style="font-size: 10pt">Telephone number, including area code, of agent for service</DIV>



<P align="center" style="font-size: 10pt"><B>Copies to:</B>



<P align="center" style="font-size: 10pt"><B>Ira N. Rosner, Esq.<BR>
Greenberg Traurig, P.A.<BR>
1221 Brickell Avenue<BR>
Miami, Florida 33131<BR>
(305)&nbsp;579-0500</B>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>CALCULATION OF REGISTRATION FEE</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="37%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="11%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed number of</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed maximum</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Title of securities</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>shares to be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>offering price</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>maximum aggregate</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>to be registered</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>registered(1)(2)</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>per share</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>offering price</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>registration fee</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock, $0.01 par value,
underlying options to be issued
under the Pediatrix Medical Group,
Inc. 2004 Incentive Compensation Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,718,750</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">63.07</TD>
    <TD nowrap>(3)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">108,401,562.50</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">13,734.48</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom" style="padding-top: 0em">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock, $0.01 par value,
underlying options previously issued
under the Pediatrix Medical Group,
Inc. 2004 Incentive Compensation Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">281,250</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">61.97</TD>
    <TD nowrap>(4)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">17,412,187.50</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,208.26</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock, $0.01 par value, to be
issued in connection with the
Pediatrix Medical Group of Puerto
Rico Thrift and Profit Sharing
Plan(5)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">63.07</TD>
    <TD nowrap>(6)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">315,350</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">39.95</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="top" style="padding-top: 0em">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock, $0.01 par value,
underlying options previously issued under the Magella
Healthcare Corporation Stock Option and Restricted Stock Purchase Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59,211</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="center" nowrap>$13.00 for 32,124 shares
(7)<BR>$24.05 for 12,466 shares (7)<BR>$20.80 for 14,621 shares (7)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,021,536.10</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">129.43</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>




<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pursuant to Rule&nbsp;416 of the Securities Act of 1933, as amended (the
&#147;Securities Act&#148;), this registration statement shall also cover any
additional shares of common stock, $0.01 par value (the &#147;Common Stock&#148;),
of Pediatrix Medical Group, Inc. (the &#147;Registrant&#148;) which become issuable
under the Pediatrix Medical Group, Inc. 2004 Incentive Compensation Plan
(the &#147;Incentive Plan&#148;), the Pediatrix Medical Group of Puerto Rico Thrift
and Profit Sharing Plan (the &#147;Puerto Rico Plan&#148;), or the Magella
Healthcare Corporation Stock Option and Restricted Stock Purchase Plan
(the &#147;Magella Plan&#148;) by reason of any stock dividend, stock split,
recapitalization or other similar transaction effected without the receipt
of consideration which results in an increase in the number of our
outstanding shares of Common Stock.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This registration statement also covers rights to purchase the
Registrant&#146;s Series&nbsp;A Junior Participating Preferred Stock that presently
are attached to and trade with the Common Stock. Any value attributable to
such rights is reflected in the market price of the Common Stock.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the registration fee in
accordance with Rules 457(h) of the Securities Act on the basis of the
average of the high and low price of a share of Common Stock as reported
by the New York Stock Exchange on December&nbsp;7, 2004.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(4)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the registration fee in
accordance with Rules 457(h) of the Securities Act on the basis of the
exercise price of $61.97 with respect to options to purchase an aggregate
of 281,250 shares of Common Stock granted under the Incentive Plan.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(5)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In addition, pursuant to Rule 416(c) under the Securities Act, this
registration statement also covers an indeterminate amount of interests to
be offered or sold pursuant to the Puerto Rico Plan.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(6)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the registration fee in
accordance with Rule 457(h) of the Securities Act on the basis of the
average of the high and low price of a share of Common Stock as reported
by the New York Stock Exchange on December&nbsp;7, 2004.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(7)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the registration fee in
accordance with Rule 457(h) of the Securities Act on the basis of (i)&nbsp;the
exercise price of $13.00 with respect to options to purchase an aggregate
of 32,124 shares of Common Stock granted under the Magella Plan , (ii)&nbsp;the
exercise price of $20.80 with respect to options to purchase an aggregate
of 14,621 shares of Common Stock granted under the Magella Plan and (iii)
the exercise price of $24.05 with respect to options to purchase an
aggregate of 12,466 shares of Common Stock granted under the Magella Plan.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="center" style="font-size: 10pt"><B>EXPLANATORY NOTE</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Registration Statement will be used to register shares of common
stock, par value of $0.01 per share (the &#147;Common Stock&#148;), of the registrant, as
well as, plan interests to be offered or sold pursuant to the Pediatrix Medical
Group of Puerto Rico Thrift and Profit Sharing Plan (the &#147;Puerto Rico Plan&#148;).
Pursuant to General Instruction A.2 to Form S-8, this Registration Statement is
being filed concurrently with the filing of the Plan&#146;s Annual Report on Form
11-K for the fiscal year ended December&nbsp;31, 2003.


<P align="center" style="font-size: 10pt"><B>PART I. INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The information specified by Items 1 and 2 of Part&nbsp;I of Form S-8 is
omitted from this filing in accordance with the provisions of Rule&nbsp;428 of the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and the introductory
Note to Part&nbsp;I of Form S-8.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The documents containing the information specified in Part&nbsp;I of Form S-8
will be sent or given to participating employees as specified by Rule 428(b) of
the Securities Act. Such documents and the documents incorporated by reference
herein pursuant to Item&nbsp;3 of Part&nbsp;II hereof, taken together, constitute a
prospectus that meets the requirements of Section 10(a) of the Securities Act.


<P align="center" style="font-size: 10pt"><B>PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>



<P align="left" style="font-size: 10pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents, which have been filed with the Securities and
Exchange Commission, are hereby incorporated by reference into this
registration statement:


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our Annual Report on Form 10-K for the fiscal year ended
December&nbsp;31, 2003;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our Quarterly Reports on Form 10-Q for the quarters ended
March&nbsp;31, 2004, June&nbsp;30, 2004 and September&nbsp;30, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our Current Reports on Form 8-K filed on February&nbsp;20, 2004,
April&nbsp;9, 2004, May&nbsp;24, 2004, August&nbsp;2, 2004, August&nbsp;3, 2004,
September&nbsp;29, 2004, November&nbsp;4, 2004 and November&nbsp;12, 2004 (not
including any information furnished under Items 2.02 or 7.01 of any
such Form 8-K);</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our Proxy Statement on Schedule&nbsp;14A filed on April&nbsp;9, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Puerto Rico Plan&#146;s Annual Report on Form 11-K for the
fiscal year ended December&nbsp;31, 2003;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of our common stock contained in our
Registration Statement on Form 8-A (Registration No.&nbsp;001-12111)
filed with the Securities and Exchange Commission on September&nbsp;4,
1996 and any amendments to such Registration Statement filed
subsequently thereto, including all amendments or reports filed for
the purpose of updating such description; and</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the rights to purchase our Series&nbsp;A Junior
Participating Preferred Stock contained in our Registration
Statement on Form 8-A (Registration No.&nbsp;001-14922) filed with the
Securities and Exchange Commission on April&nbsp;6, 1999 and any
amendments to such Registration Statement filed subsequently
thereto, including any amendments or reports filed for the purpose
of updating such description.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, all documents subsequently filed by us pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act (not including any information
furnished under Items 2.02 or 7.01 of Form 8-K, which information is not
incorporated by reference herein) prior to the filing of a post-effective
amendment which indicates that all securities offered have been sold or which
deregisters all securities then remaining unsold, will be deemed to be
incorporated herein by reference and to be a part of this registration
statement from the date of filing of such documents. Any statement contained
in a document incorporated herein by reference will be deemed to be modified


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<P align="left" style="font-size: 10pt">or superseded for purposes of this registration statement to the extent
that a statement contained herein, or in a subsequently filed document
incorporated herein by reference, modifies or supersedes the statement. Any
statement modified or superseded will not be deemed, except as modified or
superseded, to constitute a part of this registration statement.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;4. Description of Securities.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the securities being registered hereunder is being passed
upon for us by Greenberg Traurig, P.A., Miami, Florida. Cesar Alvarez, the
President and Chief Executive Officer of Greenberg Traurig, P.A., is one of our
directors. As of December&nbsp;9, 2004, Mr.&nbsp;Alvarez beneficially owns options to
acquire 29,000 shares of our common stock, all of which are presently
exercisable.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Florida Business Corporation Act permits a corporation to indemnify
the following persons (using a case-by-case determination) against liabilities
arising in the following circumstances:


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;any person who was or is party to any proceeding by reason of his or
her service as a director, officer, employee or agent of the corporation; or


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;any person serving in such capacity, at the request of the
corporation, for another corporation or business entity.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To be indemnified, a person seeking indemnification must have acted in
good faith and in a manner he or she reasonably believed to be in, or not
opposed to, the best interests of the corporation. With respect to any
criminal action or proceeding, such person must have had no reasonable cause to
believe his or her conduct was unlawful. Under Florida law the corporation can
indemnify such a person who is a party to any proceeding by or in the right of
the corporation against expenses and amounts paid in settlement which were
actually and reasonably incurred in connection with the defense or settlement
of the proceeding. Such indemnification may not exceed the board of directors&#146;
estimated expense of litigating the matter to a conclusion. No indemnification
shall be made in respect of any issue as to which such person shall have been
adjudged to be liable unless, and only to the extent that, a court shall
determine, in view of all circumstances, that such person is fairly and
reasonably entitled to indemnity for such expenses which such court shall deem
proper.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Florida Business Corporation Act, indemnification for expenses
actually and reasonably incurred in the defense of any proceeding is mandatory
to the extent that a director, officer, employee or agent is successful in such
defense. Florida law also allows a corporation to provide any other or further
indemnification or advancement of expenses to its directors, officers,
employees or agents; however such indemnification or advancement of expenses
may not extend to situations where a final adjudication establishes that such
person&#146;s actions, or omissions to act, were material to the cause of action so
adjudicated and constitute:


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;a criminal violation, unless such person had reasonable cause to
believe his conduct was lawful or had no reasonable cause to believe his
conduct was unlawful;


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;a transaction from which such person derived an improper personal
benefit;


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;in the case of a director, a circumstance under which the director
would be liable for authorizing an improper distribution; or


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;willful misconduct or conscious disregard for the best interests of
the corporation in a proceeding by or in the right of the corporation to
procure a judgment in its favor, or in a proceeding by or in the right of a
shareholder.


<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amended and restated articles of incorporation of the registrant
provide that the registrant shall indemnify and may advance expenses to its
officers and directors to the fullest extent permitted by the current law. The
registrant has secured insurance covering the registrant and its directors and
officers and those of its principal subsidiaries and affiliate companies
against certain liabilities.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant has entered into indemnification agreements with each
member of its board of directors and its executive officers. The
indemnification agreements require, among other things, that the registrant
indemnify to the fullest extent permitted by law and advance to each
indemnified director and executive officer all related expenses, subject to
reimbursement if it is subsequently determined that indemnification is not
permitted. Under the indemnification agreements, the registrant must also
indemnify and advance all expenses incurred by an indemnified director or
executive officer seeking to enforce his or her rights under the
indemnification agreements and purchase and generally maintain in effect
directors&#146; and officers&#146; liability insurance during the term, and for a period
of five years following the termination, of each director&#146;s and executive
officer&#146;s employment. Although the indemnification agreements offer
substantially the same scope of coverage afforded by law, they provide greater
assurance to directors and executive officers that indemnification will be
available, because, as contracts, they cannot be modified unilaterally in the
future by the board of directors or the stockholders to eliminate the rights
they provide.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;7. Exemption from Registration Claimed.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;8. Exhibits</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See &#147;Exhibit&nbsp;Index&#148; on page II-1 below.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant has submitted or will submit the Puerto Rico Plan and any
amendment thereto to the Internal Revenue Service (&#147;IRS&#148;) in a timely manner
and has made or will make all changes required by the IRS in order to qualify
the Puerto Rico Plan.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9. Undertakings</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The undersigned registrant hereby undertakes:


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;To include any prospectus required by Section&nbsp;10(a)(3) of the
Securities Act of 1933 (the &#147;Securities Act&#148;);


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent not more than a 20&nbsp;percent change in the
maximum aggregate offering price set forth in the &#147;Calculation of Registration
Fee&#148; table in the effective registration statement;


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;


<P align="left" style="font-size: 10pt">provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the



<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<P align="left" style="font-size: 10pt">Commission by the Registrant pursuant to Section&nbsp;13 or 15(d) of the Exchange
Act that are incorporated by reference in this registration statement.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial <I>bona
fide </I>offering thereof.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of
the offering.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
registrant&#146;s annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act that is incorporated by reference in the registration statement
shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.


<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Sunrise, State of Florida on this 9th day of
December, 2004.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>PEDIATRIX MEDICAL GROUP, INC.</B></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Roger J. Medel, M.D.
<HR size="1" noshade width="50%" align="left"></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Roger J. Medel, M.D.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the trustee
(or such other person who administers the Pediatrix Medical Group of Puerto
Rico Thrift and Profit Sharing Plan) has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Sunrise, State of Florida on this 9th day of
December, 2004.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>PEDIATRIX MEDICAL GROUP PUERTO RICO<BR>
THRIFT AND PROFIT SHARING PLAN</B></TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Karl B. Wagner
<HR size="1" noshade width="50%" align="left"></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karl B. Wagner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Financial Officer, Sponsor</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>POWER OF ATTORNEY</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each person whose signature appears below hereby appoints Thomas W.
Hawkins and Karl B. Wagner his true and lawful attorney-in-fact with authority
to execute in the name of each such person, and to file with the Securities and
Exchange Commission, together with any exhibits thereto and other documents
therewith, any and all amendments (including without limitation post-effective
amendments) to this registration statement necessary or advisable to enable the
registrant to comply with the Securities Act of 1933, as amended, and any
rules, regulations and requirements of the Securities and Exchange Commission
in respect thereof, which amendments may make such other changes in the
registration statement as the aforesaid attorney-in-fact executing the same
deems appropriate. Pursuant to the requirements of the Act, this registration
statement has been signed below by the following persons in the capacities and
on the dates indicated.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="19%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Signature</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Title</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Date</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Cesar L. Alvarez</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Chairman of the Board
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Cesar L. Alvarez</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Roger J. Medel, M.D.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">and Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Roger J. Medel, M.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Karl B. Wagner
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Chief Financial Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">and Treasurer
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Karl B. Wagner</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Waldemar A. Carlo, M.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Waldemar A. Carlo, M.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Michael B. Fernandez</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Michael B. Fernandez</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="19%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Signature</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Title</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Date</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Roger K. Freeman, M.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December 9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Roger K. Freeman, M.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Paul G. Gabos</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Paul G. Gabos</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Lawrence M. Mullen</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Lawrence M. Mullen</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Enrique J. Sosa, Ph.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">December&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Enrique J. Sosa, Ph.D.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="89%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Number</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Articles of Designations of Series&nbsp;A Junior Participating Preferred Stock
(incorporated by reference to Exhibit&nbsp;3.1 to the registrant&#146;s Current Report on
Form&nbsp;8-K dated March&nbsp;31, 1999).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rights Agreement dated as of March&nbsp;31, 1999, between the registrant and
BankBoston, N.A., as rights agent, including the form of Articles of Designations
of Series&nbsp;A Junior Participating Preferred Stock and the form of Rights
Certificate (incorporated by reference to Exhibit&nbsp;4.1 to the registrant&#146;s Current
Report on Form&nbsp;8-K dated March&nbsp;31, 1999).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pediatrix Medical Group of Puerto Rico Thrift and Profit Sharing Plan.*</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Greenberg Traurig, P.A.*</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of PricewaterhouseCoopers LLP*</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Greenberg Traurig, P.A. (contained in its opinion filed as Exhibit&nbsp;5.1
hereto).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (contained on the
signature pages of this Registration Statement).</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="left" style="font-size: 10pt">* Filed herewith.



<P align="center" style="font-size: 10pt">9
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g92297sv8.htm", "description": "PEDIATRIX MEDICAL GROUP, INC. FORM S-8", "secsgml_size_bytes": 54905}]
{"company-data": {"conformed-name": "PEDIATRIX MEDICAL GROUP INC", "cik": "0000893949", "assigned-sic": "8060", "irs-number": "650271219", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-121125", "film-number": "041194501"}, "business-address": {"street1": "1301 CONCORD TERRACE", "city": "SUNRISE", "state": "FL", "zip": "33323", "phone": "9543840175"}, "mail-address": {"street1": "1301 CONCORD TERRACE", "city": "SUNRISE", "state": "FL", "zip": "33326"}}
PEDIATRIX MEDICAL GROUP, INC. FORM S-8
As filed with the Securities and Exchange Commission on December 9, 2004
Registration
No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
PEDIATRIX MEDICAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Florida
65-0271219
(State or other jurisdiction of incorporation
or
organization)
(IRS Employer
Identification Number)
1301 Concord Terrace
Sunrise, Florida 33323-2825
(Address of Principal Executive Offices
)
Pediatrix Medical Group, Inc. 2004 Incentive Compensation Plan
Pediatrix Medical Group of Puerto Rico Thrift and Profit Sharing Plan
Magella Healthcare Corporation Stock Option and Restricted Stock Purchase Plan
(Full title of the Plans)
Thomas W. Hawkins, Esq.
Senior Vice President,
General Counsel and Secretary
Pediatrix Medical Group, Inc.
1301 Concord Terrace
Sunrise, Florida 33323-2825
(Name and address of agent for service)
(954) 384-0175
Telephone number, including area code, of agent for service
Copies to:
Ira N. Rosner, Esq.
Greenberg Traurig, P.A.
1221 Brickell Avenue
Miami, Florida 33131
(305) 579-0500
CALCULATION OF REGISTRATION FEE
Proposed number of
Proposed maximum
Proposed
Title of securities
shares to be
offering price
maximum aggregate
Amount of
to be registered
registered(1)(2)
per share
offering price
registration fee
Common Stock, $0.01 par value,
underlying options to be issued
under the Pediatrix Medical Group,
Inc. 2004 Incentive Compensation Plan
1,718,750
$
63.07
(3)
$
108,401,562.50
$
13,734.48
Common Stock, $0.01 par value,
underlying options previously issued
under the Pediatrix Medical Group,
Inc. 2004 Incentive Compensation Plan
281,250
$
61.97
(4)
$
17,412,187.50
$
2,208.26
Common Stock, $0.01 par value, to be
issued in connection with the
Pediatrix Medical Group of Puerto
Rico Thrift and Profit Sharing
Plan(5)
5,000
$
63.07
(6)
$
315,350
$
39.95
Common Stock, $0.01 par value,
underlying options previously issued under the Magella
Healthcare Corporation Stock Option and Restricted Stock Purchase Plan
59,211
$13.00 for 32,124 shares
(7)
$24.05 for 12,466 shares (7)
$20.80 for 14,621 shares (7)
$
1,021,536.10
$
129.43
(1)
Pursuant to Rule 416 of the Securities Act of 1933, as amended (the
"Securities Act"), this registration statement shall also cover any
additional shares of common stock, $0.01 par value (the "Common Stock"),
of Pediatrix Medical Group, Inc. (the "Registrant") which become issuable
under the Pediatrix Medical Group, Inc. 2004 Incentive Compensation Plan
(the "Incentive Plan"), the Pediatrix Medical Group of Puerto Rico Thrift
and Profit Sharing Plan (the "Puerto Rico Plan"), or the Magella
Healthcare Corporation Stock Option and Restricted Stock Purchase Plan
(the "Magella Plan") by reason of any stock dividend, stock split,
recapitalization or other similar transaction effected without the receipt
of consideration which results in an increase in the number of our
outstanding shares of Common Stock.
(2)
This registration statement also covers rights to purchase the
Registrant's Series A Junior Participating Preferred Stock that presently
are attached to and trade with the Common Stock. Any value attributable to
such rights is reflected in the market price of the Common Stock.
(3)
Estimated solely for the purpose of calculating the registration fee in
accordance with Rules 457(h) of the Securities Act on the basis of the
average of the high and low price of a share of Common Stock as reported
by the New York Stock Exchange on December 7, 2004.
(4)
Estimated solely for the purpose of calculating the registration fee in
accordance with Rules 457(h) of the Securities Act on the basis of the
exercise price of $61.97 with respect to options to purchase an aggregate
of 281,250 shares of Common Stock granted under the Incentive Plan.
(5)
In addition, pursuant to Rule 416(c) under the Securities Act, this
registration statement also covers an indeterminate amount of interests to
be offered or sold pursuant to the Puerto Rico Plan.
(6)
Estimated solely for the purpose of calculating the registration fee in
accordance with Rule 457(h) of the Securities Act on the basis of the
average of the high and low price of a share of Common Stock as reported
by the New York Stock Exchange on December 7, 2004.
(7)
Estimated solely for the purpose of calculating the registration fee in
accordance with Rule 457(h) of the Securities Act on the basis of (i) the
exercise price of $13.00 with respect to options to purchase an aggregate
of 32,124 shares of Common Stock granted under the Magella Plan , (ii) the
exercise price of $20.80 with respect to options to purchase an aggregate
of 14,621 shares of Common Stock granted under the Magella Plan and (iii)
the exercise price of $24.05 with respect to options to purchase an
aggregate of 12,466 shares of Common Stock granted under the Magella Plan.
EXPLANATORY NOTE
This Registration Statement will be used to register shares of common
stock, par value of $0.01 per share (the "Common Stock"), of the registrant, as
well as, plan interests to be offered or sold pursuant to the Pediatrix Medical
Group of Puerto Rico Thrift and Profit Sharing Plan (the "Puerto Rico Plan").
Pursuant to General Instruction A.2 to Form S-8, this Registration Statement is
being filed concurrently with the filing of the Plan's Annual Report on Form
11-K for the fiscal year ended December 31, 2003.
PART I. INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information specified by Items 1 and 2 of Part I of Form S-8 is
omitted from this filing in accordance with the provisions of Rule 428 of the
Securities Act of 1933, as amended (the "Securities Act"), and the introductory
Note to Part I of Form S-8.
The documents containing the information specified in Part I of Form S-8
will be sent or given to participating employees as specified by Rule 428(b) of
the Securities Act. Such documents and the documents incorporated by reference
herein pursuant to Item 3 of Part II hereof, taken together, constitute a
prospectus that meets the requirements of Section 10(a) of the Securities Act.
PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have been filed with the Securities and
Exchange Commission, are hereby incorporated by reference into this
registration statement:
(a)
Our Annual Report on Form 10-K for the fiscal year ended
December 31, 2003;
(b)
Our Quarterly Reports on Form 10-Q for the quarters ended
March 31, 2004, June 30, 2004 and September 30, 2004;
(c)
Our Current Reports on Form 8-K filed on February 20, 2004,
April 9, 2004, May 24, 2004, August 2, 2004, August 3, 2004,
September 29, 2004, November 4, 2004 and November 12, 2004 (not
including any information furnished under Items 2.02 or 7.01 of any
such Form 8-K);
(d)
Our Proxy Statement on Schedule 14A filed on April 9, 2004;
(e)
The Puerto Rico Plan's Annual Report on Form 11-K for the
fiscal year ended December 31, 2003;
(f)
The description of our common stock contained in our
Registration Statement on Form 8-A (Registration No. 001-12111)
filed with the Securities and Exchange Commission on September 4,
1996 and any amendments to such Registration Statement filed
subsequently thereto, including all amendments or reports filed for
the purpose of updating such description; and
(g)
The description of the rights to purchase our Series A Junior
Participating Preferred Stock contained in our Registration
Statement on Form 8-A (Registration No. 001-14922) filed with the
Securities and Exchange Commission on April 6, 1999 and any
amendments to such Registration Statement filed subsequently
thereto, including any amendments or reports filed for the purpose
of updating such description.
In addition, all documents subsequently filed by us pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act (not including any information
furnished under Items 2.02 or 7.01 of Form 8-K, which information is not
incorporated by reference herein) prior to the filing of a post-effective
amendment which indicates that all securities offered have been sold or which
deregisters all securities then remaining unsold, will be deemed to be
incorporated herein by reference and to be a part of this registration
statement from the date of filing of such documents. Any statement contained
in a document incorporated herein by reference will be deemed to be modified
3
or superseded for purposes of this registration statement to the extent
that a statement contained herein, or in a subsequently filed document
incorporated herein by reference, modifies or supersedes the statement. Any
statement modified or superseded will not be deemed, except as modified or
superseded, to constitute a part of this registration statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
The validity of the securities being registered hereunder is being passed
upon for us by Greenberg Traurig, P.A., Miami, Florida. Cesar Alvarez, the
President and Chief Executive Officer of Greenberg Traurig, P.A., is one of our
directors. As of December 9, 2004, Mr. Alvarez beneficially owns options to
acquire 29,000 shares of our common stock, all of which are presently
exercisable.
Item 6. Indemnification of Directors and Officers.
The Florida Business Corporation Act permits a corporation to indemnify
the following persons (using a case-by-case determination) against liabilities
arising in the following circumstances:
(i) any person who was or is party to any proceeding by reason of his or
her service as a director, officer, employee or agent of the corporation; or
(ii) any person serving in such capacity, at the request of the
corporation, for another corporation or business entity.
To be indemnified, a person seeking indemnification must have acted in
good faith and in a manner he or she reasonably believed to be in, or not
opposed to, the best interests of the corporation. With respect to any
criminal action or proceeding, such person must have had no reasonable cause to
believe his or her conduct was unlawful. Under Florida law the corporation can
indemnify such a person who is a party to any proceeding by or in the right of
the corporation against expenses and amounts paid in settlement which were
actually and reasonably incurred in connection with the defense or settlement
of the proceeding. Such indemnification may not exceed the board of directors'
estimated expense of litigating the matter to a conclusion. No indemnification
shall be made in respect of any issue as to which such person shall have been
adjudged to be liable unless, and only to the extent that, a court shall
determine, in view of all circumstances, that such person is fairly and
reasonably entitled to indemnity for such expenses which such court shall deem
proper.
Under the Florida Business Corporation Act, indemnification for expenses
actually and reasonably incurred in the defense of any proceeding is mandatory
to the extent that a director, officer, employee or agent is successful in such
defense. Florida law also allows a corporation to provide any other or further
indemnification or advancement of expenses to its directors, officers,
employees or agents; however such indemnification or advancement of expenses
may not extend to situations where a final adjudication establishes that such
person's actions, or omissions to act, were material to the cause of action so
adjudicated and constitute:
(i) a criminal violation, unless such person had reasonable cause to
believe his conduct was lawful or had no reasonable cause to believe his
conduct was unlawful;
(ii) a transaction from which such person derived an improper personal
benefit;
(iii) in the case of a director, a circumstance under which the director
would be liable for authorizing an improper distribution; or
(iv) willful misconduct or conscious disregard for the best interests of
the corporation in a proceeding by or in the right of the corporation to
procure a judgment in its favor, or in a proceeding by or in the right of a
shareholder.
4
The amended and restated articles of incorporation of the registrant
provide that the registrant shall indemnify and may advance expenses to its
officers and directors to the fullest extent permitted by the current law. The
registrant has secured insurance covering the registrant and its directors and
officers and those of its principal subsidiaries and affiliate companies
against certain liabilities.
The registrant has entered into indemnification agreements with each
member of its board of directors and its executive officers. The
indemnification agreements require, among other things, that the registrant
indemnify to the fullest extent permitted by law and advance to each
indemnified director and executive officer all related expenses, subject to
reimbursement if it is subsequently determined that indemnification is not
permitted. Under the indemnification agreements, the registrant must also
indemnify and advance all expenses incurred by an indemnified director or
executive officer seeking to enforce his or her rights under the
indemnification agreements and purchase and generally maintain in effect
directors' and officers' liability insurance during the term, and for a period
of five years following the termination, of each director's and executive
officer's employment. Although the indemnification agreements offer
substantially the same scope of coverage afforded by law, they provide greater
assurance to directors and executive officers that indemnification will be
available, because, as contracts, they cannot be modified unilaterally in the
future by the board of directors or the stockholders to eliminate the rights
they provide.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits
See "Exhibit Index" on page II-1 below.
The registrant has submitted or will submit the Puerto Rico Plan and any
amendment thereto to the Internal Revenue Service ("IRS") in a timely manner
and has made or will make all changes required by the IRS in order to qualify
the Puerto Rico Plan.
Item 9. Undertakings
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933 (the "Securities Act");
(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent not more than a 20 percent change in the
maximum aggregate offering price set forth in the "Calculation of Registration
Fee" table in the effective registration statement;
(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the
5
Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange
Act that are incorporated by reference in this registration statement.
(2) That, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona
fide
offering thereof.
(3) To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of
the offering.
(b) The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act, each filing of the
registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act that is incorporated by reference in the registration statement
shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
6
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Sunrise, State of Florida on this 9th day of
December, 2004.
PEDIATRIX MEDICAL GROUP, INC.
By:
/s/ Roger J. Medel, M.D.
Roger J. Medel, M.D.
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, the trustee
(or such other person who administers the Pediatrix Medical Group of Puerto
Rico Thrift and Profit Sharing Plan) has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Sunrise, State of Florida on this 9th day of
December, 2004.
PEDIATRIX MEDICAL GROUP PUERTO RICO
THRIFT AND PROFIT SHARING PLAN
By:
/s/ Karl B. Wagner
Karl B. Wagner
Chief Financial Officer, Sponsor
POWER OF ATTORNEY
Each person whose signature appears below hereby appoints Thomas W.
Hawkins and Karl B. Wagner his true and lawful attorney-in-fact with authority
to execute in the name of each such person, and to file with the Securities and
Exchange Commission, together with any exhibits thereto and other documents
therewith, any and all amendments (including without limitation post-effective
amendments) to this registration statement necessary or advisable to enable the
registrant to comply with the Securities Act of 1933, as amended, and any
rules, regulations and requirements of the Securities and Exchange Commission
in respect thereof, which amendments may make such other changes in the
registration statement as the aforesaid attorney-in-fact executing the same
deems appropriate. Pursuant to the requirements of the Act, this registration
statement has been signed below by the following persons in the capacities and
on the dates indicated.
Signature
Title
Date
/s/ Cesar L. Alvarez
Chairman of the Board
December 9, 2004
Cesar L. Alvarez
/s/ Roger J. Medel, M.D.
Chief Executive Officer
and Director
December 9, 2004
Roger J. Medel, M.D.
/s/ Karl B. Wagner
Chief Financial Officer
and Treasurer
December 9, 2004
Karl B. Wagner
/s/ Waldemar A. Carlo, M.D.
Director
December 9, 2004
Waldemar A. Carlo, M.D.
/s/ Michael B. Fernandez
Director
December 9, 2004
Michael B. Fernandez
7
Signature
Title
Date
/s/ Roger K. Freeman, M.D.
Director
December 9, 2004
Roger K. Freeman, M.D.
/s/ Paul G. Gabos
Director
December 9, 2004
Paul G. Gabos
/s/ Lawrence M. Mullen
Director
December 9, 2004
Lawrence M. Mullen
/s/ Enrique J. Sosa, Ph.D.
Director
December 9, 2004
Enrique J. Sosa, Ph.D.
8
EXHIBIT INDEX
Exhibit
Number
Description
4.1
Articles of Designations of Series A Junior Participating Preferred Stock
(incorporated by reference to Exhibit 3.1 to the registrant's Current Report on
Form 8-K dated March 31, 1999).
4.2
Rights Agreement dated as of March 31, 1999, between the registrant and
BankBoston, N.A., as rights agent, including the form of Articles of Designations
of Series A Junior Participating Preferred Stock and the form of Rights
Certificate (incorporated by reference to Exhibit 4.1 to the registrant's Current
Report on Form 8-K dated March 31, 1999).
4.3
Pediatrix Medical Group of Puerto Rico Thrift and Profit Sharing Plan.*
5.1
Opinion of Greenberg Traurig, P.A.*
23.1
Consent of PricewaterhouseCoopers LLP*
23.2
Consent of Greenberg Traurig, P.A. (contained in its opinion filed as Exhibit 5.1
hereto).
24.1
Power of Attorney (contained on the
signature pages of this Registration Statement).
* Filed herewith.
9